Investor
Rejuveron
Baar · Switzerland
Centenara Labs develops and invests in early-stage therapeutics that target geriatric diseases to expand human healthspan and longevity.
Stage
Series B
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Global
Sectors
About
The firm develops and invests in therapies that target geriatric diseases. It focuses on transforming discoveries in aging research into therapies that extend good health years. The organisation builds a broad pipeline by founding or investing in early-staged therapeutics companies. Its portfolio targets the hallmarks of aging to address unmet needs in age-related diseases.
How to approach
Contact the firm to start a conversation through their website contact form or email.
Portfolio · 3 · tap a company to read about it